USPTO serial 79303290
WAKUNAGA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 5, 2021
- Examiner
- STURMAN, JOSHUA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with WAKUNAGA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations in the nature of anti-tussive expectorants, analgesics, anti-inflammatories, eye drops, and topical dermatological preparations for the treatment of gastrointestinal diseases, colds, rhinitis, hemorrhoids, dermatitis and eczema; Chinese traditional medicinal herbs; reagent paper for medical purposes; adhesive tapes for medical purposes; gauze for dressings; medicated compresses; capsules sold empty for pharmaceuticals; eyepatches for medical purposes; sanitary tampons; sanitary pads; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; breast-nursing pads; cotton swabs for medical purposes; teeth filling material; babies' diapers; napkins for incontinents; fly catching paper; mothproofing paper; lacteal flour for babies; nutritional supplements; dietary supplements for animals; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; food for babies; nutraceutical preparations for use as a dietary supplement; semen for artificial insemination; medicated ointments for pharmaceutical purposes, namely, treating dermatological conditions, hemorrhoids, athlete's foot and ringworm; pharmaceutical preparations for skin care; lotions for pharmaceutical purposes, namely, pharmaceutical skin lotions; Medicinal tonics, namely, medicinal drinks; germicides; air purifying preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Wakunaga Pharmaceutical Co., Ltd.
- Other trademarks owned by Wakunaga Pharmaceutical Co., Ltd.
- Other trademarks owned by Wakunaga Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Similar marks named WAKUNAGA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 12, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 18, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 25, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 25, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 5, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 5, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 20, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 20, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 30, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 16, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 16, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 16, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 16, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 16, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 25, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 24, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 24, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 17, 2021 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 15, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 7, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 6, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 5, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 5, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 18, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 18, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 9, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 6, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 5, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 5, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 4, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |